Cardiovascular Pathology
Volume 19, Issue 2 , Pages e29-e32 , March 2010

Mycobacterium bovis abdominal aortic and femoral artery aneurysms following intravesical bacillus Calmette–Guérin therapy for bladder cancer

  • Cecilia T. Costiniuk

      Affiliations

    • Department of Medicine, University of Ottawa, Ottawa, ON, Canada
    • C.T. Costiniuk and A.A. Sharapov are joint first authors.
    • ,
  • Anton A. Sharapov

      Affiliations

    • Department of Surgery, University of Ottawa, Ottawa, ON, Canada
    • C.T. Costiniuk and A.A. Sharapov are joint first authors.
    • ,
  • Gregory W. Rose

      Affiliations

    • Department of Medicine, University of Ottawa, Ottawa, ON, Canada
    • Corresponding Author InformationCorresponding author. Division of Infectious Diseases, Ottawa Hospital, Civic Campus, 1053 Carling Ave., Ottawa, ON, Canada K1Y 4E9. Tel.: +1 613 761 4155; fax: +1 613 761 5260.
    • ,
  • John P. Veinot

      Affiliations

    • Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, ON, Canada
    • ,
  • Marc Desjardins

      Affiliations

    • Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, ON, Canada
    • ,
  • Tim M. Brandys

      Affiliations

    • Department of Surgery, University of Ottawa, Ottawa, ON, Canada
    • ,
  • Kathryn N. Suh

      Affiliations

    • Department of Medicine, University of Ottawa, Ottawa, ON, Canada

Received 2 June 2008 ,Revised 4 August 2008 ,Accepted 15 September 2008.

References 

  1. Soravia-Dunand VA, Loo VG, Salit IE. Aortitis due to Salmonella: report of 10 cases and comprehensive review of the literature. Clin Infect Dis. 1999;29:862–868
  2. Moneta GL, Taylor LM, Yeager RA, et al. Surgical treatment of infected aortic aneurysm. Am J Surg. 1998;175:396–399
  3. Harding GE, Lawlor DK. Ruptured mycotic aortic aneurysm secondary to Mycobacterium bovis after intravesical treatment with bacillus Calmette–Guérin. J Vasc Surg. 2007;46:131–134
  4. Wolf YG, Wolf DG, Higginbottom PA, Dilley RB. Infection of a ruptured aortic aneurysm and an aortic graft with bacille Calmette–Guérin after intravesical administration for bladder cancer. J Vasc Surg. 1995;22:80–84
  5. Schellhammer PF, Ladaga LE, Fillion MB. Bacillus Calmette–Guérin for superficial transitional cell carcinoma of the bladder. J Urol. 1986;135:261–264
  6. Hellinger WC, Oldenburg WA, Alvarez S. Vascular and other serious infections with Mycobacteria bovis bacillus after therapy for bladder cancer. South Med J. 1995;88:1212–1216
  7. Spelman D. Mycotic aneurysms. [USA. UpToDate] In:  Rose BD,  Waltham MA editor. UpToDate. 2008;[Last accessed April 15, 2008]
  8. Brown SL, Busuttil RW, Baker JD, Machleder HI, Moore WE, Barker WF. Bacteriologic and surgical determinants of survival in patients with mycotic aneurysms. J Vasc Surg. 1984;1:541–547
  9. Barza MJ, Blum JH, Graeme-Cook FM. Case records of the Massachusetts General Hospital: case 29-1998—a 57-year-old man with fever and jaundice after intravesical instillation of bacille Calmette–Guérin for bladder cancer. N Engl J Med. 1998;339:831–837
  10. Lamm DL. Efficacy and safety of bacille Calmette–Guérin immunotherapy in superficial bladder cancer. Clin Infect Dis. 2000;31(Suppl 3):S86–S90
  11. Deresiewicz RL, Stone RM, Aster JC. Fatal disseminated mycobacterial infection following intravesical bacillus Calmette–Guérin. J Urol. 1990;144:1331–1333
  12. Kamphuis JT, Buiting AG, Miseré JF, van Berge Henegouwen DP, van Soolingen D, Rensma PL. BCG immunotherapy: be cautious of granulomatous BCG infection and mycotic aneurysm as late complications of intravesical BCG instillations. Neth J Med. 2001;58:71–75

PII: S1054-8807(08)00124-5

doi: 10.1016/j.carpath.2008.09.003

Cardiovascular Pathology
Volume 19, Issue 2 , Pages e29-e32 , March 2010

Article Tools

* Image Usage & Resolution